LeaderPortfolio
family
Wolfgang Marguerre & family
Rank #490
GERMANYHealthcarePharmaceuticals

Wolfgang Marguerre & family

Net Worth
$7.748B
0% (24h)
Wolfgang Marguerre, a German billionaire, is the founder and chairman of Octapharma AG, a global healthcare company specializing in plasma-derived therapies. Born in Heidelberg, Germany, in 1941, Marguerre earned an MBA from INSEAD. His career began in pharmaceuticals in 1975, and he founded Octapharma in 1983. Under his leadership, Octapharma has become a major player in the biopharmaceutical industry, with a focus on treatments for hemophilia, immune deficiencies, and critical care. His net worth is estimated at $7.9 billion, and his contributions extend to significant philanthropic initiatives, particularly in education and support for individuals with bleeding disorders.

How to read Wolfgang Marguerre & family's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Wolfgang Marguerre & family, we anchor the narrative to Pharmaceuticals and Pharmaceuticals, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $7.748B alongside global rank #490, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (GERMANY) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Wolfgang Marguerre was born in Heidelberg, Germany, on January 30, 1941. He grew up in Heidelberg during the post-World War II period. His early life was marked by an emphasis on education, which later influenced his entrepreneurial pursuits. He studied Political and Economic Science at Heidelberg University and obtained an MBA from INSEAD in 1972.

Rise to Success

Marguerre's career in the pharmaceutical industry began in 1975 at Baxter's Travenol Laboratories, where he managed the plasma derivatives business. In 1978, he became Senior Executive Vice President of Revlon Healthcare Group. In 1983, he founded Octapharma in Switzerland. The company initially focused on developing safer and improved plasma-derived therapies for hemophilia patients. Octapharma has since grown into a global biopharmaceutical leader, manufacturing products for hematology, immunology, and critical care.

Key Business Strategies

Octapharma's success stems from a focus on high-quality plasma fractionation. The company expanded its manufacturing capabilities through strategic acquisitions and built state-of-the-art facilities. Key strategies include innovation in therapies, global expansion, and an emphasis on patient care and medical advancement.

Philanthropy

Marguerre is involved in various philanthropic endeavors, primarily supporting education and medical initiatives. He founded the Octapharma Scholarship at INSEAD, providing financial assistance to MBA students. He also sponsors children with bleeding disorders through Save One Life, aligning with Octapharma's focus on therapies for rare diseases. He has donated $17.5 million to renovate Theater Heidelberg and $1.13 million to support refugee integration in Heidelberg.

Career Timeline

2011

Awarded the Gold Decoration of Honour for Services to the Republic of Austria

Recognized for contributions to the pharmaceutical industry.

2009

Awarded the Légion d'honneur

Received the highest decoration bestowed by France.

1983

Founded Octapharma AG

Established Octapharma with a focus on safer therapies for hemophilia patients.

1978

Senior Executive Vice President of Revlon Healthcare Group

Assumed leadership responsibilities within the plasma division.

1975

Manager of plasma derivatives business at Baxter's Travenol Laboratories

Began career in the pharmaceutical sector, developing expertise in plasma-based products.

Philanthropic Impact

Education$25K (per student)

Octapharma Scholarship

Supports MBA students from various countries.

MedicalUndisclosed

Save One Life

Sponsors children with bleeding disorders.

Arts$17.5M

Heidelberg Theater Renovation

Donation for the renovation of the Theater Heidelberg.

Social Services$1.13M

Refugee Integration

Supports the integration of refugees in Heidelberg.

Key Business Ventures & Holdings

CompanyStakeValue
Octapharma AG

Net Worth History

In-Depth Analysis

Early Life

Wolfgang Marguerre was born in Heidelberg, Germany, on January 30, 1941. He grew up in Heidelberg during the post-World War II period. His early life was marked by an emphasis on education, which later influenced his entrepreneurial pursuits. He studied Political and Economic Science at Heidelberg University and obtained an MBA from INSEAD in 1972.

Rise to Success

Marguerre's career in the pharmaceutical industry began in 1975 at Baxter's Travenol Laboratories, where he managed the plasma derivatives business. In 1978, he became Senior Executive Vice President of Revlon Healthcare Group. In 1983, he founded Octapharma in Switzerland. The company initially focused on developing safer and improved plasma-derived therapies for hemophilia patients. Octapharma has since grown into a global biopharmaceutical leader, manufacturing products for hematology, immunology, and critical care.

Key Business Strategies

Octapharma's success stems from a focus on high-quality plasma fractionation. The company expanded its manufacturing capabilities through strategic acquisitions and built state-of-the-art facilities. Key strategies include innovation in therapies, global expansion, and an emphasis on patient care and medical advancement.

Philanthropy

Marguerre is involved in various philanthropic endeavors, primarily supporting education and medical initiatives. He founded the Octapharma Scholarship at INSEAD, providing financial assistance to MBA students. He also sponsors children with bleeding disorders through Save One Life, aligning with Octapharma's focus on therapies for rare diseases. He has donated $17.5 million to renovate Theater Heidelberg and $1.13 million to support refugee integration in Heidelberg.

Data Sources & Methodology

Figures for Wolfgang Marguerre & family are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.